International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7844590
Original Article
The Association between Elevated Serum Uric Acid and Acute Ischemic Stroke in Adult
Published
April 19, 2023
Abstract
Background: Elevated serum uric acid levels have been associated with an increased risk of stroke. However, the prevalence of hyperuricemia in patients with acute ischemic stroke and its association with gender and age remain unclear. Materials and Methods: This retrospective study included 110 patients with acute ischemic stroke who were admitted to a single center. Serum uric acid levels were measured within 24 hours of admission. Data on age, gender, and other clinical and laboratory variables were collected from medical records. Results: The study found that 27.3% of the patients had elevated serum uric acid levels, with a mean serum uric acid level of 6.2 mg/dL. The majority of the patients had serum uric acid levels within the normal range, and only 8.2% of the patients had low serum uric acid levels. The study also found that the mean serum uric acid level was higher in males compared to females and that there was a significant association between age and serum uric acid levels, with the highest levels observed in the age group of 80 years and above. Conclusion: The present study highlights the high prevalence of hyperuricemia in patients with acute ischemic stroke, with males and older patients being at a higher risk. These findings underscore the importance of monitoring serum uric acid levels in patients with acute ischemic stroke, especially in high-risk populations. Further studies are needed to investigate the possible mechanisms underlying the association between hyperuricemia and stroke, which may provide new insights into the pathophysiology of stroke and potential therapeutic targets.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1044 Views
431 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved